[96a5a0]: / output / allTrials / identified / NCT04889820_identified.json

Download this file

599 lines (599 with data), 28.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
{
"info": {
"nct_id": "NCT04889820",
"official_title": "Oncologic oUTcomes of Neoadjuvant Chemotherapy for obSTructive Colon cAncer After steNt Decompression (OUTSTAND Trial); Multicenter Randomized Controlled Trial",
"inclusion_criteria": "* i. Age : 20 years old or more and lesser than 75 years old ii. Agreement of this study iii. Clinical stage II or III colon cancer with colonic obstruction which is confirmed by pathologic review and imaging study.\n\niv. Colon cancer located beween distal T colon and Rectosigmoid junction colon which is defined as a tumor above 15cm from anal verge.\n\nv. Colonocopic fiding: tumor involving whole circumference of the lumen, impossible to pass endoscope through the tumor vi. SEMS placement vii. no colonic injury and successful decompression of the colon with in 48 hours after SEMS placement.\n\nviii. ECOG performance 0-2 ix. ASA ≤ 3 x. Appropriate function of the vital organ (acceptable liver enzyme and BUN/Cr) xi. Appropriate function of hematopoietic system (platelet ≥100,000ul, neutrophil ≥2,000ul) xii. If the patient is female in fertile period, urine hCG test is negative and she has no plan of pregnancy with 6 months after the termiation of whole treatment.\n\nxiii. If the patient is male in fertile period, he agrees with contraception during treatment period and 6 months after the termination of whole treatment.\nHealthy volunteers allowed\nMust have minimum age of 20 Years\nMust have maximum age of 74 Years",
"exclusion_criteria": "* i. any suspicious distant metastasis ii. any other primary malignant lesion iii. Clinical stage T1or T2 and N0 iv. the sign of perforation or severe ischemia requiring ememgency operation v. the complication related to SEMS placement (severe bleeding and perforation after SEMS placement) vi. ASA 4 or more vii. ECOG 3 or more viii. colonic obstruction by benign stricture ix. pregnant woman or woman who is breastfeeding x. the paitents who already enrolled into other study or are taking medicine related to any clinical trial xi. the patients who are taking sorivudine xii. the patients who are taking Tegafur/gimeracil/oteracil xiii. the patietns who have a medical history of hypersensitivity reaction to 5-FU, oxaliplatin, leucovorin,or any medication including platinum.\n\nxiv. Inappropriate function of vital organ (impaired renal function, elevated liver enzyme, and so on ) xv. Inappropriate function of hematopoietic system (platelet <100,000ul, neutrophil < 2,000ul) xvi. Genetic problem such as galactose intolerance, Lapp lactase deficiency, or glucose-galatose malabsorption)",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* i. Age : 20 years old or more and lesser than 75 years old ii. Agreement of this study iii. Clinical stage II or III colon cancer with colonic obstruction which is confirmed by pathologic review and imaging study.",
"criterions": [
{
"exact_snippets": "Age : 20 years old or more and lesser than 75 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 20,
"unit": "years"
},
{
"operator": "<",
"value": 75,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "Agreement of this study",
"criterion": "study agreement",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
},
{
"exact_snippets": "Clinical stage II or III colon cancer",
"criterion": "colon cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"II",
"III"
]
}
]
},
{
"exact_snippets": "colonic obstruction",
"criterion": "colonic obstruction",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "confirmed by pathologic review and imaging study",
"criterion": "confirmation method",
"requirements": [
{
"requirement_type": "methods",
"expected_value": [
"pathologic review",
"imaging study"
]
}
]
}
]
},
{
"line": "iv. Colon cancer located beween distal T colon and Rectosigmoid junction colon which is defined as a tumor above 15cm from anal verge.",
"criterions": [
{
"exact_snippets": "Colon cancer located beween distal T colon and Rectosigmoid junction colon",
"criterion": "colon cancer location",
"requirements": [
{
"requirement_type": "location",
"expected_value": "between distal T colon and Rectosigmoid junction colon"
}
]
},
{
"exact_snippets": "tumor above 15cm from anal verge",
"criterion": "tumor location",
"requirements": [
{
"requirement_type": "distance from anal verge",
"expected_value": {
"operator": ">",
"value": 15,
"unit": "cm"
}
}
]
}
]
},
{
"line": "v. Colonocopic fiding: tumor involving whole circumference of the lumen, impossible to pass endoscope through the tumor vi. SEMS placement vii. no colonic injury and successful decompression of the colon with in 48 hours after SEMS placement.",
"criterions": [
{
"exact_snippets": "Colonocopic fiding: tumor involving whole circumference of the lumen",
"criterion": "tumor involvement",
"requirements": [
{
"requirement_type": "extent",
"expected_value": "whole circumference of the lumen"
}
]
},
{
"exact_snippets": "impossible to pass endoscope through the tumor",
"criterion": "endoscope passage",
"requirements": [
{
"requirement_type": "possibility",
"expected_value": false
}
]
},
{
"exact_snippets": "SEMS placement",
"criterion": "SEMS placement",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "no colonic injury",
"criterion": "colonic injury",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "successful decompression of the colon with in 48 hours after SEMS placement",
"criterion": "colon decompression",
"requirements": [
{
"requirement_type": "success",
"expected_value": true
},
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 48,
"unit": "hours"
}
}
]
}
]
},
{
"line": "viii. ECOG performance 0-2 ix. ASA ≤ 3 x. Appropriate function of the vital organ (acceptable liver enzyme and BUN/Cr) xi. Appropriate function of hematopoietic system (platelet ≥100,000ul, neutrophil ≥2,000ul) xii. If the patient is female in fertile period, urine hCG test is negative and she has no plan of pregnancy with 6 months after the termiation of whole treatment.",
"criterions": [
{
"exact_snippets": "ECOG performance 0-2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
},
{
"exact_snippets": "ASA ≤ 3",
"criterion": "ASA physical status classification",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "Appropriate function of the vital organ (acceptable liver enzyme and BUN/Cr)",
"criterion": "vital organ function",
"requirements": [
{
"requirement_type": "function",
"expected_value": "acceptable liver enzyme and BUN/Cr"
}
]
},
{
"exact_snippets": "Appropriate function of hematopoietic system (platelet ≥100,000ul, neutrophil ≥2,000ul)",
"criterion": "hematopoietic system function",
"requirements": [
{
"requirement_type": "platelet count",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "ul"
}
},
{
"requirement_type": "neutrophil count",
"expected_value": {
"operator": ">=",
"value": 2000,
"unit": "ul"
}
}
]
},
{
"exact_snippets": "If the patient is female in fertile period, urine hCG test is negative",
"criterion": "urine hCG test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "If the patient is female in fertile period, ... she has no plan of pregnancy with 6 months after the termiation of whole treatment.",
"criterion": "pregnancy plan",
"requirements": [
{
"requirement_type": "plan",
"expected_value": "no plan of pregnancy within 6 months after treatment"
}
]
}
]
},
{
"line": "xiii. If the patient is male in fertile period, he agrees with contraception during treatment period and 6 months after the termination of whole treatment.",
"criterions": [
{
"exact_snippets": "patient is male in fertile period",
"criterion": "male fertility",
"requirements": [
{
"requirement_type": "fertility status",
"expected_value": "fertile"
}
]
},
{
"exact_snippets": "he agrees with contraception during treatment period and 6 months after the termination of whole treatment",
"criterion": "contraception agreement",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 20 Years",
"criterions": [
{
"exact_snippets": "minimum age of 20 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 20,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 74 Years",
"criterions": [
{
"exact_snippets": "maximum age of 74 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 74,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* i. any suspicious distant metastasis ii. any other primary malignant lesion iii. Clinical stage T1or T2 and N0 iv. the sign of perforation or severe ischemia requiring ememgency operation v. the complication related to SEMS placement (severe bleeding and perforation after SEMS placement) vi. ASA 4 or more vii. ECOG 3 or more viii. colonic obstruction by benign stricture ix. pregnant woman or woman who is breastfeeding x. the paitents who already enrolled into other study or are taking medicine related to any clinical trial xi. the patients who are taking sorivudine xii. the patients who are taking Tegafur/gimeracil/oteracil xiii. the patietns who have a medical history of hypersensitivity reaction to 5-FU, oxaliplatin, leucovorin,or any medication including platinum.",
"criterions": [
{
"exact_snippets": "any suspicious distant metastasis",
"criterion": "distant metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "any other primary malignant lesion",
"criterion": "primary malignant lesion",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Clinical stage T1or T2 and N0",
"criterion": "clinical stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"T1",
"T2"
]
},
{
"requirement_type": "nodal involvement",
"expected_value": "N0"
}
]
},
{
"exact_snippets": "the sign of perforation or severe ischemia requiring ememgency operation",
"criterion": "perforation or severe ischemia",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "requiring emergency operation"
}
]
},
{
"exact_snippets": "the complication related to SEMS placement (severe bleeding and perforation after SEMS placement)",
"criterion": "complication related to SEMS placement",
"requirements": [
{
"requirement_type": "complications",
"expected_value": [
"severe bleeding",
"perforation"
]
}
]
},
{
"exact_snippets": "ASA 4 or more",
"criterion": "ASA score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "ECOG 3 or more",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "colonic obstruction by benign stricture",
"criterion": "colonic obstruction",
"requirements": [
{
"requirement_type": "cause",
"expected_value": "benign stricture"
}
]
},
{
"exact_snippets": "pregnant woman or woman who is breastfeeding",
"criterion": "pregnancy or breastfeeding",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"pregnant",
"breastfeeding"
]
}
]
},
{
"exact_snippets": "the paitents who already enrolled into other study or are taking medicine related to any clinical trial",
"criterion": "enrollment in other study or taking medicine related to clinical trial",
"requirements": [
{
"requirement_type": "status",
"expected_value": true
}
]
},
{
"exact_snippets": "the patients who are taking sorivudine",
"criterion": "sorivudine intake",
"requirements": [
{
"requirement_type": "intake",
"expected_value": true
}
]
},
{
"exact_snippets": "the patients who are taking Tegafur/gimeracil/oteracil",
"criterion": "Tegafur/gimeracil/oteracil intake",
"requirements": [
{
"requirement_type": "intake",
"expected_value": true
}
]
},
{
"exact_snippets": "the patietns who have a medical history of hypersensitivity reaction to 5-FU, oxaliplatin, leucovorin,or any medication including platinum",
"criterion": "hypersensitivity reaction",
"requirements": [
{
"requirement_type": "medical history",
"expected_value": [
"5-FU",
"oxaliplatin",
"leucovorin",
"any medication including platinum"
]
}
]
}
]
},
{
"line": "xiv. Inappropriate function of vital organ (impaired renal function, elevated liver enzyme, and so on ) xv. Inappropriate function of hematopoietic system (platelet <100,000ul, neutrophil < 2,000ul) xvi. Genetic problem such as galactose intolerance, Lapp lactase deficiency, or glucose-galatose malabsorption)",
"criterions": [
{
"exact_snippets": "Inappropriate function of vital organ (impaired renal function",
"criterion": "renal function",
"requirements": [
{
"requirement_type": "function",
"expected_value": "impaired"
}
]
},
{
"exact_snippets": "Inappropriate function of vital organ ... elevated liver enzyme",
"criterion": "liver enzyme levels",
"requirements": [
{
"requirement_type": "level",
"expected_value": "elevated"
}
]
},
{
"exact_snippets": "Inappropriate function of hematopoietic system (platelet <100,000ul",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "count",
"expected_value": {
"operator": "<",
"value": 100000,
"unit": "ul"
}
}
]
},
{
"exact_snippets": "Inappropriate function of hematopoietic system ... neutrophil < 2,000ul",
"criterion": "neutrophil count",
"requirements": [
{
"requirement_type": "count",
"expected_value": {
"operator": "<",
"value": 2000,
"unit": "ul"
}
}
]
},
{
"exact_snippets": "Genetic problem such as galactose intolerance",
"criterion": "galactose intolerance",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Genetic problem such as ... Lapp lactase deficiency",
"criterion": "Lapp lactase deficiency",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Genetic problem such as ... glucose-galatose malabsorption",
"criterion": "glucose-galactose malabsorption",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}